{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:38:25Z","timestamp":1791898705698,"version":"4.3.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CARIGEST SA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cryptococcal meningitis (CM) and disseminated histoplasmosis (DH) are common in people with human immunodeficiency virus (PWH) and diagnosed by detecting cryptococcal antigen (CrAg) and Histoplasma antigen (HistoAg), respectively. In Ghana, CM and DH are rarely suspected by clinicians due to limited epidemiological data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study was conducted among PWH in Ghana who are unwell. Sociodemographic and clinical data were collected by questionnaire. Serum and\/or urine were screened for CrAg and HistoAg, using IMMY CrAg lateral flow assay (LFA) and IMMY Histoplasma enzyme immunoassay (EIA) kits, respectively, regardless of symptoms. Samples run with IMMY Histoplasma EIA were simultaneously run with Optimum Imaging Diagnostics (OIDx) Histoplasma LFA. Laboratory investigations were conducted by the research team, and diagnosis incorporating clinical assessment, screening, and confirmatory testing results and treatment decisions were made by the clinical team. Treatment and outcome information on CM and DH patients were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 150 participants were recruited. There were 73% (n\u2009=\u2009109) females, and the age range was 18\u201362 years. The prevalence rates of CrAg and HistoAg were 2.7% (4 of 150) and 4.7% (5 of 107), respectively. The OIDx Histoplasma LFA showed a high concordance (98.4%) with the IMMY Histoplasma EIA. All antigen-positive cases by standard tests were diagnosed with CM and DH. Antifungal treatment was given in 5 patients and follow-up revealed 2 deaths and 3 recoveries.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Histoplasmosis among PWH may be more common than previously anticipated and may be more frequent than cryptococcosis in Ghana. The performance of the OIDx Histoplasma LFA should be further explored.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac277","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T05:14:02Z","timestamp":1654233242000},"source":"Crossref","is-referenced-by-count":31,"title":["Cryptococcal and <i>Histoplasma<\/i> Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx <i>Histoplasma<\/i> Lateral Flow Assay and IMMY <i>Histoplasma<\/i> Enzyme Immunoassay"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3120-106X","authenticated-orcid":false,"given":"Bright K","family":"Ocansey","sequence":"first","affiliation":[{"name":"Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Otoo","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Noguchi Memorial Institute of Medical Research, University of Ghana , Legon , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Asamoah","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ganu","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi P","family":"Berko","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Oladele","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella A","family":"Amankwa","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bismark","family":"Opoku-Asare","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Agyei","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Internal Medicine, Komfo Anokye Teaching Hospital , Kumasi , Ghana"},{"name":"Department of Medicine, Kwame Nkrumah University of Science and Technology , Kumasi , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"George","sequence":"additional","affiliation":[{"name":"Laboratory Department, Juaboso Government Hospital , Juaboso , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleischer C N","family":"Kotey","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University of Ghana Medical School , Korle-Bu , Ghana"},{"name":"FleRhoLife Research Consult , Teshie , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-1265","authenticated-orcid":false,"given":"Chris","family":"Kosmidis","sequence":"additional","affiliation":[{"name":"Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester , United Kingdom"},{"name":"National Aspergillosis Centre, Manchester University NHS Foundation Trust , Manchester , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Puplampu","sequence":"additional","affiliation":[{"name":"Fevers Unit, Department of Medicine, Korle-Bu Teaching Hospital , Korle-Bu , Ghana"},{"name":"Department of Medicine and Therapeutics, University of Ghana Medical School , Korle-Bu , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Japheth A","family":"Opintan","sequence":"additional","affiliation":[{"name":"Laboratory Department, Juaboso Government Hospital , Juaboso , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Denning","sequence":"additional","affiliation":[{"name":"Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"2022073009595674700_ofac277-B1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tim.2014.01.001","article-title":"A neglected epidemic: fungal infections in HIV\/AIDS","volume":"22","author":"Armstrong-James","year":"2014","journal-title":"Trends Microbiol"},{"key":"2022073009595674700_ofac277-B2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0468","article-title":"Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized","volume":"371","author":"Denning","year":"2016","journal-title":"Phil Trans R Soc B Biol Sci"},{"key":"2022073009595674700_ofac277-B3","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1473-3099(17)30303-1","article-title":"Fungal infections in HIV\/AIDS","volume":"17","author":"Limper","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2022073009595674700_ofac277-B4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2022073009595674700_ofac277-B5","article-title":"Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-Infected adults, adolescents and children: supplement to the 2016 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"World Health Organization"},{"key":"2022073009595674700_ofac277-B6","doi-asserted-by":"publisher","first-page":"e0210105","DOI":"10.1371\/journal.pone.0210105","article-title":"Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis","volume":"14","author":"Rajasingham","year":"2019","journal-title":"PLoS One"},{"key":"2022073009595674700_ofac277-B7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab010","article-title":"Cryptococcal antigen screening among antiretroviral therapy-experienced people with HIV with viral load nonsuppression in rural Uganda","volume":"8","author":"Baluku","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022073009595674700_ofac277-B8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac004","article-title":"High burden of cryptococcal meningitis among ART-experienced HIV-infected patients in Northern Uganda in the era of \u201ctest and treat\u201d: implications for cryptococcal screening programs","author":"Okwir","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2022073009595674700_ofac277-B9","doi-asserted-by":"publisher","first-page":"e75585","DOI":"10.1371\/journal.pone.0075585","article-title":"Comparison of cryptococcal antigenemia between antiretroviral na\u00efve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia","volume":"8","author":"Beyene","year":"2013","journal-title":"PLoS One"},{"key":"2022073009595674700_ofac277-B10","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/cid\/ciz1069","article-title":"Cryptococcal antigenemia in human immunodeficiency virus antiretroviral therapy-experienced Ugandans with virologic failure","volume":"71","author":"Mpoza","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022073009595674700_ofac277-B11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/QAD.0000000000002556","article-title":"A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration","volume":"34","author":"Alufandika","year":"2020","journal-title":"AIDS"},{"key":"2022073009595674700_ofac277-B12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","article-title":"Short Communication: low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana","volume":"16","author":"Mamoojee","year":"2011","journal-title":"Trop Med Int Health"},{"key":"2022073009595674700_ofac277-B13","volume-title":"Cryptococcal Meningitis in Hospitalized HIV Patients at the Fevers\u2019 Unit, Korle-Bu Teaching Hospital, Accra","author":"Awadzi","year":"2015"},{"key":"2022073009595674700_ofac277-B14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/trstmh\/trx083","article-title":"High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana","volume":"111","author":"Opintan","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022073009595674700_ofac277-B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1476-0711-11-28","article-title":"Aetiological agents of cerebrospinal meningitis: a retrospective study from a teaching hospital in Ghana","volume":"11","author":"Owusu","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2022073009595674700_ofac277-B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4314\/gmj.v49i1.2","article-title":"Causes of death in hospitalized HIV patients in the early anti-retroviral therapy era","volume":"49","author":"Lartey","year":"2015","journal-title":"Ghana Med J"},{"key":"2022073009595674700_ofac277-B17","doi-asserted-by":"publisher","first-page":"e0006046","DOI":"10.1371\/journal.pntd.0006046","article-title":"Histoplasmosis in Africa: an emerging or a neglected disease?","volume":"12","author":"Oladele","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2022073009595674700_ofac277-B18","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3201\/eid2111.150278","article-title":"Histoplasmosis in HIV-infected persons, Yaound\u00e9, Cameroon","volume":"21","author":"Mandengue","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2022073009595674700_ofac277-B19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1473-3099(18)30354-2","article-title":"Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study","volume":"18","author":"Adenis","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2022073009595674700_ofac277-B20","article-title":"Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV"},{"key":"2022073009595674700_ofac277-B21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.9734\/jammr\/2021\/v33i330825","article-title":"Disseminated histoplasmosis; a threat in advanced HIV disease population in sub-Saharan Africa?","author":"Mandengue","year":"2021","journal-title":"J Adv Med Med Res"},{"key":"2022073009595674700_ofac277-B22","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211008675","article-title":"Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities","volume":"8","author":"Kuate","year":"2021","journal-title":"Therap Adv Infect"},{"key":"2022073009595674700_ofac277-B23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/QAD.0000000000002631","article-title":"Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV","volume":"34","author":"Medina","year":"2020","journal-title":"AIDS"},{"key":"2022073009595674700_ofac277-B24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/jof7040268","article-title":"A rapid screening program for histoplasmosis, tuberculosis, and cryptococcosis reduces mortality in HIV patients from Guatemala","volume":"7","author":"Medina","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022073009595674700_ofac277-B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/mmy\/myv081","article-title":"Seroprevalence of histoplasmosis in Kampala, Uganda","volume":"54","author":"Bahr","year":"2016","journal-title":"Med Mycol"},{"key":"2022073009595674700_ofac277-B26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10903-017-0595-3","article-title":"Seroprevalence of histoplasmosis in Somali, Burmese, and Hmong refugees residing in Thailand and Kenya","volume":"20","author":"Bahr","year":"2018","journal-title":"J Immigr Minor Health"},{"key":"2022073009595674700_ofac277-B27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/myc.13303","article-title":"Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in Central American people living with HIV","volume":"64","author":"Caceres","year":"2021","journal-title":"Mycoses"},{"key":"2022073009595674700_ofac277-B28","doi-asserted-by":"publisher","first-page":"106226","DOI":"10.1016\/j.mimet.2021.106226","article-title":"Screening for acute disseminated histoplasmosis in HIV disease using urinary antigen detection enzyme immunoassay: a pilot study in Cameroon","volume":"185","author":"Kuate","year":"2021","journal-title":"J Microbiol Methods"},{"key":"2022073009595674700_ofac277-B29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/myc.13071","article-title":"Screening for invasive fungal disease using non-culture-based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa","volume":"63","author":"van Schalkwyk","year":"2020","journal-title":"Mycoses"},{"key":"2022073009595674700_ofac277-B30","doi-asserted-by":"publisher","first-page":"e0009215","DOI":"10.1371\/journal.pntd.0009215","article-title":"Diagnostic accuracy of antigen detection in urine and molecular assays testing in different clinical samples for the diagnosis of progressive disseminated histoplasmosis in patients living with HIV\/AIDS: a prospective multicenter study in Mexico","volume":"15","author":"Mart\u00ednez-Gamboa","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2022073009595674700_ofac277-B31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00409","article-title":"Cryptococcal antigen screening in asymptomatic HIV-infected antiretroviral na\u00efve patients in Cameroon and evaluation of the new semi-quantitative Biosynex CryptoPS test","volume":"9","author":"Temfack","year":"2018","journal-title":"Front Microbiol"},{"key":"2022073009595674700_ofac277-B32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1373\/jalm.2018.028910","article-title":"Comparison of urine antigen assays for the diagnosis of histoplasma capsulatum infection","volume":"4","author":"Persaud","year":"2019","journal-title":"J Appl Lab Med"},{"key":"2022073009595674700_ofac277-B33","doi-asserted-by":"publisher","first-page":"e02046","DOI":"10.1128\/JCM.02046-19","article-title":"Evaluation of serum cryptococcal antigen testing using two novel semiquantitative lateral flow assays in persons with cryptococcal antigenemia","volume":"58","author":"Skipper","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2022073009595674700_ofac277-B34","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3814835","article-title":"The current state of laboratory fungal diagnostics and availability of antifungal treatment in Africa: a ECMM and ISHAM survey","volume-title":"SSRN Electronic J","author":"Driemeyer","year":"2021"},{"key":"2022073009595674700_ofac277-B35","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.3390\/jof5020038","article-title":"Estimated burden of serious fungal infections in Ghana","volume":"5","author":"Ocansey","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2022073009595674700_ofac277-B36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/myc.13023","article-title":"Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS","volume":"63","author":"C\u00e1ceres","year":"2020","journal-title":"Mycoses"},{"key":"2022073009595674700_ofac277-B37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jof7100799","article-title":"Validation and concordance analysis of a new lateral flow assay for detection of histoplasma antigen in urine","volume":"7","author":"C\u00e1ceres","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2022073009595674700_ofac277-B38","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab454","article-title":"Diagnosis of histoplasmosis using the MVista Histoplasma galactomannan antigen qualitative lateral flow\u2013based immunoassay: a multicenter study","volume":"8","author":"Abdallah","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022073009595674700_ofac277-B39","article-title":"Rapid Testing","author":"OIDx"},{"key":"2022073009595674700_ofac277-B40","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022073009595674700_ofac277-B41","article-title":"The selection and use of essential in vitro diagnostics - TRS 1031","author":"World Health Organization"},{"key":"2022073009595674700_ofac277-B42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11046-021-00602-9","article-title":"Evaluation of OIDx histoplasma urinary antigen EIA","volume":"187","author":"Caceres","year":"2021","journal-title":"Mycopathologia"},{"key":"2022073009595674700_ofac277-B43","article-title":"Guidelines for Antiretroviral Therapy in Ghana1. 144","author":"Ghana AIDS Commission"},{"key":"2022073009595674700_ofac277-B44","author":"National Health Insurance Scheme. Benefits Package"},{"key":"2022073009595674700_ofac277-B45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw055","article-title":"Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence","volume":"3","author":"Oladele","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2022073009595674700_ofac277-B46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cid\/civ936","article-title":"Cryptococcal antigen screening in patients initiating ART in South Africa: a prospective cohort study","volume":"62","author":"Longley","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022073009595674700_ofac277-B47","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2022073009595674700_ofac277-B48","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/jac\/dkw325","article-title":"Global access to antifungal therapy and its variable cost","volume":"71","author":"Kneale","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2022073009595674700_ofac277-B49"},{"key":"2022073009595674700_ofac277-B50","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/cid\/cix613","article-title":"Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)-positive human immunodeficiency virus-infected persons in an Ethiopian CrAg screening program","volume":"65","author":"Beyene","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022073009595674700_ofac277-B51","doi-asserted-by":"publisher","first-page":"e02575","DOI":"10.1128\/mBio.02575-19","article-title":"Fluconazole monotherapy is a suboptimal option for initial treatment of cryptococcal meningitis because of emergence of resistance","volume":"10","author":"Hope","year":"2019","journal-title":"mBio"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac277\/43935240\/ofac277.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac277\/45028998\/ofac277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac277\/45028998\/ofac277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T10:01:18Z","timestamp":1659175278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac277\/6599102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac277","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,6,3]]},"article-number":"ofac277"}}